The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice

Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-11-0524
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Clinical Cancer Research
Cancer ResearchOncology
2008English

Claudin 7 Expression and Localization in the Normal Murine Mammary Gland and Murine Mammary Tumors

Breast Cancer Research
Cancer ResearchOncology
2005English

The Influence of Tamoxifen on Normal Mouse Mammary Gland Homeostasis

Breast Cancer Research
Cancer ResearchOncology
2014English

Mammary Epithelial-Specific Expression of the Integrin Linked Kinase (ILK) Results in the Induction of Mammary Gland Hyperplasias and Tumors in Transgenic Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Clinical Cancer Research
Cancer ResearchOncology
2011English

Participation of Mammary Tumor Virus in Mammary Gland Sensitivity to Prolactin in Mice

Nihon Chikusan Gakkaiho
1972English

Mammary Gland-Specific Ablation of Focal Adhesion Kinase Reduces the Incidence of P53-Mediated Mammary Tumour Formation

British Journal of Cancer
Cancer ResearchOncology
2014English

Co-Expression of Vimentin and Cytokeratin in Bitch Mammary Gland Tumors

Acta Veterinaria
Veterinary
2007English

FOXA1 Is an Essential Determinant of ER Expression and Mammary Ductal Morphogenesis

Development (Cambridge)
Developmental BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy